Smith & Nephew confirms interest in Biomet
This article was originally published in Clinica
Executive Summary
Orthopaedic company Smith & Nephew confirmed today that it has had preliminary talks with US counterpart Biomet regarding a strategic acquisition. A brief statement issued by the London, UK-based company said that no agreement had been reached. Speculation on a merger of the two companies, to form a combined unit with hip sales of $703m and knee sales of $997m, has been building since the US firm and its CEO Dane Miller parted company this spring.